| Literature DB >> 35478125 |
Nobuyasu Yoshimoto1,2, Akemi Yanagi3, Satoru Takayama4, Masaki Sakamoto4, Keisuke Tomoda4, Ken Ishikawa4, Kohei Takura4, Akifumi Kawate4, Shoryu Takayama4, Masakatsu Yamashita4, Shinya Yamamoto4, Kioto Yokoyama4, Hisanori Kani4.
Abstract
BACKGROUND/AIM: COVID-19 vaccination is now performed in most of the world to limit the spread of the disease. The first mRNA vaccine was approved in clinical settings and has specific side effects including axillary lymph node swelling, which can be misdiagnosed as breast cancer metastasis. The timing of axillary lymph node swelling and its duration are unclear. Here, we present a Japanese case and review of the existing literature. CASE REPORT: We report the case of a 67-year-old woman with breast calcification. She had regular follow ups in our hospital for this calcification and received ultrasonography of the breast and axilla at every visit. She visited 6 months before having her COVID-19 vaccination, and 7 days and 6 months after the first COVID-19 vaccination. She had a swollen axillary lymph node 7 days after the first vaccination, which although it was improved, remained for 6 months.Entities:
Keywords: COVID-19 vaccine; axillary lymph node swelling; time-course change
Mesh:
Substances:
Year: 2022 PMID: 35478125 PMCID: PMC9087108 DOI: 10.21873/invivo.12834
Source DB: PubMed Journal: In Vivo ISSN: 0258-851X Impact factor: 2.406